MedPath

Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients

Not Applicable
Conditions
Cholecystitis/Cholelithiasis
Polyp Gallbladder
Cholecystitis; Gallstone
Registration Number
NCT04670952
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

Standard Pressure Laparoscopic Cholecystectomy,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, low pressure laparoscopic cholecystectomy is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, the previous studies have presented controversial results. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Detailed Description

Standard Pressure Laparoscopic Cholecystectomy, SPLC;12-16mmHg,as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis.

According to literature, Low Pressure Laparoscopic Cholecystectomy, LPLC;8-10mmHg is thought to probably decrease cardio-pulmonary related complications and postoperative pain. However, most of the existing study have combined population with all age scale, bringing bias to the result. Our study aim to evaluate the potential pulmonary benefit of low pressure laparoscopic cholecystectomy in elderly or patients accompanied with cardio-pulmonary disorders.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
140
Inclusion Criteria
  1. Aged 18-85;
  2. Patients receiving laparoscopic cholecystectomy due to benign gallbladder diseases;
  3. Older patient or accompanied by cardiopulmonary diseases (age>60 years, hypertension, Diabetes Mellitus, coronary heart disease, arrhythmia, chronic bronchitis, emphysema, history of heart surgery, history of lung surgery, history of mediastinal surgery, asthma, et al);
  4. Aged older than 60, with or without the above diseases;
  5. American society of Aneshesiologists (ASA) II or higher;
  6. Informed consent acquired.
Exclusion Criteria
  1. Having contraindication of laparoscopic operations;
  2. History at epigastric surgery. -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change of partial pressure of carbon dioxide(pCO2)Within postoperative 30 days.

Change of pCO2 in arterial blood gas test

Secondary Outcome Measures
NameTimeMethod
visual analogue scale (VAS)During postoperative 24 hours.

For evaluation of postoperative pain degree, using VAS, scoring 1-10 scores.

operation timeDuring surgery.

skin to skin operative duration

conversion rate to open surgeryDuring surgery.

Need of conversion to open surgery duo to adhesion, hemorrhage, or other reasons.

complication rateWithin postoperative 30 days.

Rate of total postoperative complications

Trial Locations

Locations (1)

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

Peking Union Medical College Hospital
🇨🇳Beijing, Beijing, China
Hui Xu, Docor
Contact
+86-01069156874
pumchkyc@126.com
Feng Tian, Doctor
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.